MedPath
HSA Approval

BICALUTAMIDE STADA FILM COATED TABLET 50MG

SIN15134P

BICALUTAMIDE STADA FILM COATED TABLET 50MG

BICALUTAMIDE STADA FILM COATED TABLET 50MG

December 12, 2016

DCH AURIGA SINGAPORE

DCH AURIGA SINGAPORE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDCH AURIGA SINGAPORE
Licence HolderDCH AURIGA SINGAPORE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L02BB03

bicalutamide

Manufacturer Information

DCH AURIGA SINGAPORE

Kocak Farma Ilac ve Kimya Sanyi A.S.

Active Ingredients

Bicalutamide

50mg

Bicalutamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BICALUTAMIDE STADA FILM COATED TABLET 50MG - HSA Approval | MedPath